Send feedback

KL p.Phe352Val

c.1054T>G · rs9536314 · VCV311690

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 7 submitters
AlphaMissense
ambiguous
0.4881 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 18.1%, afr) — too common for a highly-penetrant pathogenic allele
Conditions
1
tumoral calcinosis, hyperphosphatemic, familial, 3

Computational evidence

Protein change
AlphaMissense0.4881ambiguous
REVEL0.409indeterminate
SaProtLLR -12.28damaging
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 6GERP 1.9, phastCons 1
Regional constrainto/e 0.97unconstrained · MANE · 48 kb · p 0.22 · regional, not allelic
Overall
CADD26.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 18.1% African / African-American · 13,536/74,928 alleles
Filtering AF 17.8% ClinGen BA1/BS1 input FAF95, joint · FAF99 17.7%
Overall 15.4% 248,912/1,612,748 alleles · common exomes 225,219/1,460,648 · genomes 23,693/152,100 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 20.9% 5
Finnishnot grpmax-eligible 19.7% 5
African / African-Americangrpmax 18.1% 6
South Asian 17.3% 6
Remaining individualsnot grpmax-eligible 16.4% 6
Middle Eastern 16.2% 6
European (non-Finnish) 15.6% 6
Amishnot grpmax-eligible 10.6% 9
Admixed American 8.35% 12
East Asian 0.0869% 1,150

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
KL
Protein
p.Phe352Val
Coding
c.1054T>G
MANE Select
NM_004795
dbSNP
rs9536314
Type
single nucleotide variant
Location
chr13:33054001 (GRCh38)
Gene constraint
LOEUF 0.917 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 89.48 · 6 PDB
Residue 352
a UniProt-annotated variant site (in allele kl-vs); the 'glycosyl hydrolase-1 1' region; an α-helix
Full KL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

tumoral calcinosis, hyperphosphatemic, familial, 3 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Familial tumoral calcinosis (Orphanet):

Inheritance
Autosomal recessive
Onset
Childhood

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/kl-p-phe352val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown